Identification of novel endogenous antisense transcripts by DNA microarray analysis targeting complementary strand of annotated genes

Koji Numata, Yuko Osada, Yuki Okada, Rintaro Saito, Noriko Hiraiwa, Hajime Nakaoka, Naoyuki Yamamoto, Kazufumi Watanabe, Kazue Okubo, Chihiro Kohama, Akio Kanai, Kuniya Abe, Hidenori Kiyosawa

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Background: Recent transcriptomic analyses in mammals have uncovered the widespread occurrence of endogenous antisense transcripts, termed natural antisense transcripts (NATs). NATs are transcribed from the opposite strand of the gene locus and are thought to control sense gene expression, but the mechanism of such regulation is as yet unknown. Although several thousand potential sense-antisense pairs have been identified in mammals, examples of functionally characterized NATs remain limited. To identify NAT candidates suitable for further functional analyses, we performed DNA microarray-based NAT screening using mouse adult normal tissues and mammary tumors to target not only the sense orientation but also the complementary strand of the annotated genes. Results: First, we designed microarray probes to target the complementary strand of genes for which an antisense counterpart had been identified only in human public cDNA sources, but not in the mouse. We observed a prominent expression signal from 66.1% of 635 target genes, and 58 genes of these showed tissue-specific expression. Expression analyses of selected examples (Acaa1b and Aard) confirmed their dynamic transcription in vivo. Although interspecies conservation of NAT expression was previously investigated by the presence of cDNA sources in both species, our results suggest that there are more examples of human-mouse conserved NATs that could not be identified by cDNA sources. We also designed probes to target the complementary strand of well-characterized genes, including oncogenes, and compared the expression of these genes between mammary cancerous tissues and non-pathological tissues. We found that antisense expression of 95 genes of 404 well-annotated genes was markedly altered in tumor tissue compared with that in normal tissue and that 19 of these genes also exhibited changes in sense gene expression. These results highlight the importance of NAT expression in the regulation of cellular events and in pathological conditions. Conclusion: Our microarray platform targeting the complementary strand of annotated genes successfully identified novel NATs that could not be identified by publically available cDNA data, and as such could not be detected by the usual sense-targeting microarray approach. Differentially expressed NATs monitored by this platform may provide candidates for investigations of gene function. An advantage of our microarray platform is that it can be applied to any genes and target samples of interest.

Original languageEnglish
Article number1471
Pages (from-to)392
Number of pages1
JournalBMC Genomics
Volume10
DOIs
Publication statusPublished - 2009 Aug 22

Fingerprint

Antisense DNA
Microarray Analysis
Oligonucleotide Array Sequence Analysis
Genes
Complementary DNA
Gene Expression
Mammals
Oncogenes

ASJC Scopus subject areas

  • Biotechnology
  • Genetics

Cite this

Identification of novel endogenous antisense transcripts by DNA microarray analysis targeting complementary strand of annotated genes. / Numata, Koji; Osada, Yuko; Okada, Yuki; Saito, Rintaro; Hiraiwa, Noriko; Nakaoka, Hajime; Yamamoto, Naoyuki; Watanabe, Kazufumi; Okubo, Kazue; Kohama, Chihiro; Kanai, Akio; Abe, Kuniya; Kiyosawa, Hidenori.

In: BMC Genomics, Vol. 10, 1471, 22.08.2009, p. 392.

Research output: Contribution to journalArticle

Numata, K, Osada, Y, Okada, Y, Saito, R, Hiraiwa, N, Nakaoka, H, Yamamoto, N, Watanabe, K, Okubo, K, Kohama, C, Kanai, A, Abe, K & Kiyosawa, H 2009, 'Identification of novel endogenous antisense transcripts by DNA microarray analysis targeting complementary strand of annotated genes', BMC Genomics, vol. 10, 1471, pp. 392. https://doi.org/10.1186/1471-2164-10-392
Numata, Koji ; Osada, Yuko ; Okada, Yuki ; Saito, Rintaro ; Hiraiwa, Noriko ; Nakaoka, Hajime ; Yamamoto, Naoyuki ; Watanabe, Kazufumi ; Okubo, Kazue ; Kohama, Chihiro ; Kanai, Akio ; Abe, Kuniya ; Kiyosawa, Hidenori. / Identification of novel endogenous antisense transcripts by DNA microarray analysis targeting complementary strand of annotated genes. In: BMC Genomics. 2009 ; Vol. 10. pp. 392.
@article{1793ee21a77e42f2869b3007dd35e89c,
title = "Identification of novel endogenous antisense transcripts by DNA microarray analysis targeting complementary strand of annotated genes",
abstract = "Background: Recent transcriptomic analyses in mammals have uncovered the widespread occurrence of endogenous antisense transcripts, termed natural antisense transcripts (NATs). NATs are transcribed from the opposite strand of the gene locus and are thought to control sense gene expression, but the mechanism of such regulation is as yet unknown. Although several thousand potential sense-antisense pairs have been identified in mammals, examples of functionally characterized NATs remain limited. To identify NAT candidates suitable for further functional analyses, we performed DNA microarray-based NAT screening using mouse adult normal tissues and mammary tumors to target not only the sense orientation but also the complementary strand of the annotated genes. Results: First, we designed microarray probes to target the complementary strand of genes for which an antisense counterpart had been identified only in human public cDNA sources, but not in the mouse. We observed a prominent expression signal from 66.1{\%} of 635 target genes, and 58 genes of these showed tissue-specific expression. Expression analyses of selected examples (Acaa1b and Aard) confirmed their dynamic transcription in vivo. Although interspecies conservation of NAT expression was previously investigated by the presence of cDNA sources in both species, our results suggest that there are more examples of human-mouse conserved NATs that could not be identified by cDNA sources. We also designed probes to target the complementary strand of well-characterized genes, including oncogenes, and compared the expression of these genes between mammary cancerous tissues and non-pathological tissues. We found that antisense expression of 95 genes of 404 well-annotated genes was markedly altered in tumor tissue compared with that in normal tissue and that 19 of these genes also exhibited changes in sense gene expression. These results highlight the importance of NAT expression in the regulation of cellular events and in pathological conditions. Conclusion: Our microarray platform targeting the complementary strand of annotated genes successfully identified novel NATs that could not be identified by publically available cDNA data, and as such could not be detected by the usual sense-targeting microarray approach. Differentially expressed NATs monitored by this platform may provide candidates for investigations of gene function. An advantage of our microarray platform is that it can be applied to any genes and target samples of interest.",
author = "Koji Numata and Yuko Osada and Yuki Okada and Rintaro Saito and Noriko Hiraiwa and Hajime Nakaoka and Naoyuki Yamamoto and Kazufumi Watanabe and Kazue Okubo and Chihiro Kohama and Akio Kanai and Kuniya Abe and Hidenori Kiyosawa",
year = "2009",
month = "8",
day = "22",
doi = "10.1186/1471-2164-10-392",
language = "English",
volume = "10",
pages = "392",
journal = "BMC Genomics",
issn = "1471-2164",
publisher = "BioMed Central",

}

TY - JOUR

T1 - Identification of novel endogenous antisense transcripts by DNA microarray analysis targeting complementary strand of annotated genes

AU - Numata, Koji

AU - Osada, Yuko

AU - Okada, Yuki

AU - Saito, Rintaro

AU - Hiraiwa, Noriko

AU - Nakaoka, Hajime

AU - Yamamoto, Naoyuki

AU - Watanabe, Kazufumi

AU - Okubo, Kazue

AU - Kohama, Chihiro

AU - Kanai, Akio

AU - Abe, Kuniya

AU - Kiyosawa, Hidenori

PY - 2009/8/22

Y1 - 2009/8/22

N2 - Background: Recent transcriptomic analyses in mammals have uncovered the widespread occurrence of endogenous antisense transcripts, termed natural antisense transcripts (NATs). NATs are transcribed from the opposite strand of the gene locus and are thought to control sense gene expression, but the mechanism of such regulation is as yet unknown. Although several thousand potential sense-antisense pairs have been identified in mammals, examples of functionally characterized NATs remain limited. To identify NAT candidates suitable for further functional analyses, we performed DNA microarray-based NAT screening using mouse adult normal tissues and mammary tumors to target not only the sense orientation but also the complementary strand of the annotated genes. Results: First, we designed microarray probes to target the complementary strand of genes for which an antisense counterpart had been identified only in human public cDNA sources, but not in the mouse. We observed a prominent expression signal from 66.1% of 635 target genes, and 58 genes of these showed tissue-specific expression. Expression analyses of selected examples (Acaa1b and Aard) confirmed their dynamic transcription in vivo. Although interspecies conservation of NAT expression was previously investigated by the presence of cDNA sources in both species, our results suggest that there are more examples of human-mouse conserved NATs that could not be identified by cDNA sources. We also designed probes to target the complementary strand of well-characterized genes, including oncogenes, and compared the expression of these genes between mammary cancerous tissues and non-pathological tissues. We found that antisense expression of 95 genes of 404 well-annotated genes was markedly altered in tumor tissue compared with that in normal tissue and that 19 of these genes also exhibited changes in sense gene expression. These results highlight the importance of NAT expression in the regulation of cellular events and in pathological conditions. Conclusion: Our microarray platform targeting the complementary strand of annotated genes successfully identified novel NATs that could not be identified by publically available cDNA data, and as such could not be detected by the usual sense-targeting microarray approach. Differentially expressed NATs monitored by this platform may provide candidates for investigations of gene function. An advantage of our microarray platform is that it can be applied to any genes and target samples of interest.

AB - Background: Recent transcriptomic analyses in mammals have uncovered the widespread occurrence of endogenous antisense transcripts, termed natural antisense transcripts (NATs). NATs are transcribed from the opposite strand of the gene locus and are thought to control sense gene expression, but the mechanism of such regulation is as yet unknown. Although several thousand potential sense-antisense pairs have been identified in mammals, examples of functionally characterized NATs remain limited. To identify NAT candidates suitable for further functional analyses, we performed DNA microarray-based NAT screening using mouse adult normal tissues and mammary tumors to target not only the sense orientation but also the complementary strand of the annotated genes. Results: First, we designed microarray probes to target the complementary strand of genes for which an antisense counterpart had been identified only in human public cDNA sources, but not in the mouse. We observed a prominent expression signal from 66.1% of 635 target genes, and 58 genes of these showed tissue-specific expression. Expression analyses of selected examples (Acaa1b and Aard) confirmed their dynamic transcription in vivo. Although interspecies conservation of NAT expression was previously investigated by the presence of cDNA sources in both species, our results suggest that there are more examples of human-mouse conserved NATs that could not be identified by cDNA sources. We also designed probes to target the complementary strand of well-characterized genes, including oncogenes, and compared the expression of these genes between mammary cancerous tissues and non-pathological tissues. We found that antisense expression of 95 genes of 404 well-annotated genes was markedly altered in tumor tissue compared with that in normal tissue and that 19 of these genes also exhibited changes in sense gene expression. These results highlight the importance of NAT expression in the regulation of cellular events and in pathological conditions. Conclusion: Our microarray platform targeting the complementary strand of annotated genes successfully identified novel NATs that could not be identified by publically available cDNA data, and as such could not be detected by the usual sense-targeting microarray approach. Differentially expressed NATs monitored by this platform may provide candidates for investigations of gene function. An advantage of our microarray platform is that it can be applied to any genes and target samples of interest.

UR - http://www.scopus.com/inward/record.url?scp=70349571889&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349571889&partnerID=8YFLogxK

U2 - 10.1186/1471-2164-10-392

DO - 10.1186/1471-2164-10-392

M3 - Article

C2 - 19698135

AN - SCOPUS:70349571889

VL - 10

SP - 392

JO - BMC Genomics

JF - BMC Genomics

SN - 1471-2164

M1 - 1471

ER -